World-wide there is estimated to be more than 430,000 people who are newly diagnosed with bladder cancer each year and 165,000 will die from the disease. Yet, until 2018, there was not one single organisation to speak as the global voice for people living with bladder cancer. The World Bladder Cancer Patient Coalition is an association bringing together representatives of national bladder cancer organisations.

World-wide there is estimated to be more than 430,000 people who are newly diagnosed with bladder cancer each year and 165,000 will die from the disease. Yet, until 2018, there was not one single organisation to speak as the global voice for people living with bladder cancer. The World Bladder Cancer Patient Coalition is an association bringing together representatives of national bladder cancer organisations.

The Mission of the organisation

Foster an international community

Promote a global community of people affected by bladder cancer

Buildalliances

Drive partnerships with health professionals, policy makers, academics, researchers and industry

Advocate for access

Campaign for better bladder cancer‘information, support, and care

(no title)

This organisation is governed by a board of directors, comprised of people diagnosed with bladder cancer, carers of people with bladder cancer or those engaged with bladder cancer organizations at a significant level.

First Word Bladder Cancer Patient Coalition meeting

The first World Bladder Cancer Patient Coalition Meeting took place on Monday 18 March 2019 from 12:00 until 17:00 in Barcelona, Spain.

The following organizations are members of the World Bladder Cancer Patient Coalition:

Bladder Cancer Advocacy Network USA

Fight Bladder Cancer UK

Bladder Cancer Canada

Bladder Cancer Australia Charity Foundation

Les Zuros – France

PaLiNUro – Italy

Blærekreftforeningen – Norway

Action Bladder Cancer UK

Bladder Cancer Awareness Australia

Contact the WBCPC if you are interested in joining the Coalition, inquiring about its activities or supporting its mission.

Subscribe to the World Bladder Cancer Patient Coalition Newsletter

This initiative benefits from the support of F. Hoffman-La Roche AG, AstraZeneca, Bayer AG, EMD Serono, Ipsen, Janssen Pharmaceutica, Merck & Co, Pfizer and Photocure. The scope and content of this webpage are the sole responsibility of the World Bladder Cancer Patient Coalition.